Structural biology generates new insights into leukemogenesis: recent publication from Matthew Smith in Nature Communications

The research team of Professor Matthew J. Smith, a young Principal Investigator at the IRIC who specializes in signalling and structural biology, recently elucidated a molecular mechanism underlying certain leukemias.

Article from the Perreault lab in Cell Reports: to better understand the thymus, the immune system’s brain

Why does the thymus ages faster than other organs? Important advance in the prevention of aging of the thymus: summary of the article from the Perreault lab in Cell Reports.

The dancing enzymes that trigger cell division

The group headed by Vincent Archambault at IRIC has made an important discovery about cell division that has just been published in the prestigious journal Nature Communications. Cell division is a fa…

The bitter-sweet truth: eIF4E sugar coats cancer cells… ready to metastasize?

The team of Professor Katherine Borden of IRIC, in collaboration with researchers from the Segal Cancer Centre of the Montreal Jewish General Hospital and the Cleveland Clinic, Ohio, USA, published a study in the scientific journal eLife describing how the eIF4E protein can alter the surface of cells to promote cancer development.

Full summary: The bitter-sweet truth: eIF4E sugar coats cancer cells… ready to metastasize?

The team of Dr. Katherine Borden, Principal Investigator at IRIC published a study in the scientific journal eLife, conducted in collaboration with Dr. Vincent Hascall and Dr. Ronald Midura, principal investigators at the Cleveland Clinic, Ohio, USA, as well as collaborators from the Segal Cancer Centre of the Montreal Jewish general Hospital.

Michel Bouvier, Chief Executive Officer of IRIC, will receive the prestigious 2017 Prix du Québec Wilder-Penfield

Montreal, October 30, 2017 –The Institute for Research in Immunology and Cancer (IRIC) of the Université de Montréal is proud to announce that its Chief Executive Officer, Michel Bouvier, will be awar…

Renewal of Marc Therrien’s mandate as Scientific Director of IRIC

Following a meeting of the Executive Committee, on October 10th, the Université de Montréal confirmed the extension of Marc Therrien’s mandate as Scientific Director of the IRIC for a second period of…

Appointment of Sébastien Carréno to the position of Director of Academic Affairs at IRIC

Sébastien Carréno, Principal Investigator at IRIC within the Cellular mechanisms of morphogenesis during mitosis and cell motility research unit, has been appointed the Institute’s Director of Aca…

Appointment and reappointment to the Institute for Research in Immunology and Cancer of the Université de Montréal Board of Directors

Montreal, August 7, 2017 – The Institute for Research in Immunology and Cancer (IRIC) of the Université de Montréal (UdeM) is pleased to announce that the UdeM Executive Committee has reappointed Mr. …

Two new appointments to IRICoR’s Board

Montreal, July 31, 2017— IRICoR (Institute for Research in Immunology and Cancer – Commercialization of Research) proudly announces the appointment of Dr. Martin Godbout, president of Hodran Consulta…

A fly, a worm and a rodent: a researcher’s recipe to success

I am a post-doctoral researcher. I am also a Doctor of Veterinary Medicine which explains why I like to work on research projects involving animal models. This type of research continues to draw criti…

Vincent-Philippe Lavallée, student at IRIC, recipient of a prestigious Vanier Canada Graduate Scholarship of the CIHR

Vincent-Philippe Lavallée, PhD student at IRIC, received an important grant from the Vanier Canada Graduate Scholarship (Vanier CGS) program.

This 3-year $150 000 scholarship from the Canadian In…

IRIC welcomed Dr. Robert Lefkowitz

Today, IRIC welcomed Dr. Robert Lefkowitz, Laureate of the 2012 Nobel Prize in Chemistry and Investigator at Howard Hughes Medical Institute. Dr. Lefkowitz is also a James B. Duke Professor of Med…

Two IRIC Investigators receive a grant (Research scholars junior 2) from the FRQS

Benjamin Kwok and Étienne Gagnon, two Principal Investigators at the Institute received a grant (Research scholars junior 2) from the Fonds de recherche du Québec – Santé (FRQS).

This program is desi…

10 IRIC Investigators receive a grant from the Canadian Institutes of Health Research (CIHR)

The Canadian Institutes of Health Research (CIHR) recently presented the grants of its Project Grant Program. For the fall competition, 10 IRIC Investigators received the valued grants, a success rate…

Agreement reached between the Hebrew University of Jerusalem and the University of Montreal and new collaborations with IRIC

Tel Aviv, May 23, 2017 – As part of his mission to Israel, the Premier of Quebec announced today an agreement between the Hebrew University of Jerusalem and the University of Montreal. It includes the…

Three IRIC students honored at UdeM’s Faculty of Medecine’s Molecular Biology program’s Scientific Day

On May 12th, 50 IRIC students gathered with other students and researchers for the UdeM Faculty of Medecine Molecular Biology Program’s Scientific Day.

This event was an opportunity for Master’s and …

IRICoR: a unique model

For the annual edition of the Canadian Society for Pharmaceutical Sciences (CSPS) and the Canadian Chapter of the Controlled Release Society (CC-CRS) conferences, Mrs. Nadine Beauger, Chief Executive …